Taiwan authorizes domestic production of at-home COVID test kits

06/17/2021 10:12 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
Image taken from the website of TaiDoc Technology Corp.
Image taken from the website of TaiDoc Technology Corp.

Taipei, June 17 (CNA) Taiwan has approved the domestic production of one type of rapid coronavirus test kits for use at home, the Food and Drug Administration (FDA) said on Friday.

The product, the first of its kind developed in Taiwan, is one type of antigen rapid tests for diagnosing COVID-19, which detects certain proteins in the virus by using a nasal swab to get a sample, according to FDA official Lin Hsin-hui (林欣慧).

The positive results offered by using the antigen rapid tests achieved an identical rate of 94 percent with those using PCR tests, Lin said, citing data from the product's developer.

The at-home COVID-19 rapid test was developed by TaiDoc Technology Corp. and mass production of the product will soon start, the FDA said.

The manufacturing company will still have to prepare a product instruction manual, labeling, sales channels, and a video showing the testing procedures before being allowed to put it on sale at pharmacies and medical device stores, Lin said, adding that the price and launch date of the test kit will be announced by the company.

The approval was given after the FDA ratified imports of two types of rapid COVID-19 home test kits to Taiwan last week to expand COVID-19 testing capacity.

(By Chang Ming-hsuan and Evelyn Kao)


    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.